![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: McNeely W. Goa K.L.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.56, Iss.6, 1998-12, pp. : 1093-1124
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sibutramine and the management of obesity
By Poston Walker S Carlos Foreyt John P
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Benefit-Risk Assessment of Sibutramine in the Management of Obesity
Drug Safety, Vol. 26, Iss. 14, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Orlistat: A Review of its Use in the Management of Obesity
By Henness Sheridan Perry Caroline M.
Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Orlistat: A Review of its Use in the Management of Patients with Obesity
By Curran Monique P. Scott Lesley J.
Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Orlistat: A Review of its Use in the Management of Obesity
Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. :